Technical Analysis for ICAD - icad inc.

Grade Last Price % Change Price Change
grade A 4.55 6.56% 0.28
ICAD closed up 6.56 percent on Thursday, January 17, 2019, on 2.66 times normal volume. The bulls were able to push the stock to a new 52-week high.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ICAD trend table...

Date Alert Name Type % Chg
Jan 17 New 52 Week Closing High Bullish 0.00%
Jan 17 Pocket Pivot Bullish Swing Setup 0.00%
Jan 17 Cup with Handle Other 0.00%
Jan 17 New 52 Week High Strength 0.00%
Jan 17 Upper Bollinger Band Walk Strength 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Above Upper BB Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 Bearish Engulfing Bearish 6.56%
Jan 16 Cup with Handle Other 6.56%

Older signals for ICAD ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier. It offers Axxent eBx system, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. It also provides computer-aided detection (CAD) solutions for digital and film-based mammography systems, including SecondLook systems that detects and identifies masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer's network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. In addition, the company offers image analysis and workflow solutions in MRI imaging comprising SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution, which provides visual and quantitative depictions of the movement of contrast agent through a lesion. Further, it provides VeraLook that supports the detection of colonic polyps in conjunction with CT Colonography; and the TotalLook MammoAdvantage system, a mammography specific digitizer. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. It sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.
Is ICAD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.76
52 Week Low 2.425
Average Volume 128,019
200-Day Moving Average 3.2699
50-Day Moving Average 3.6054
20-Day Moving Average 3.9405
10-Day Moving Average 4.195
Average True Range 0.3466
ADX 29.06
+DI 26.0467
-DI 11.5896
Chandelier Exit (Long, 3 ATRs ) 3.7202
Chandelier Exit (Short, 3 ATRs ) 4.4298
Upper Bollinger Band 4.5447
Lower Bollinger Band 3.3363
Percent B (%b) 1.0
BandWidth 30.666159
MACD Line 0.2065
MACD Signal Line 0.1586
MACD Histogram 0.0479
Fundamentals Value
Market Cap 75.51 Million
Num Shares 16.6 Million
EPS -0.56
Price-to-Earnings (P/E) Ratio -8.13
Price-to-Sales 2.98
Price-to-Book 3.16
PEG Ratio -0.58
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.38
Resistance 3 (R3) 5.35 5.06 5.24
Resistance 2 (R2) 5.06 4.85 5.07 5.19
Resistance 1 (R1) 4.80 4.72 4.93 4.83 5.15
Pivot Point 4.51 4.51 4.57 4.52 4.51
Support 1 (S1) 4.25 4.30 4.38 4.28 3.95
Support 2 (S2) 3.96 4.17 3.97 3.91
Support 3 (S3) 3.70 3.96 3.86
Support 4 (S4) 3.73